FDA Approves Sun Pharma’s Alopecia Drug Leqselvi: What Will this Mean for Patients?
Benjamin Ungar, MD, the Director of the Alopecia Center of Excellence at Mount Sinai in New York City, discusses what the U.S. Food and Drug Administration approval of Sun Pharma’s LEQSELVI (deuruxolitinib) will mean for adults with severe alopecia areata.
